Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Cancer Treatment Reviews
|
July 1, 2011
Defective homologous recombination in human cancers
A Cerbinskaite, A Mukhopadhyay, E R Plummer, et al.
Analytical Biochemistry
|
March 1, 1989
The quantitation by radioimmunoassay of 2'-deoxyuridine 5'-triphosphate in extracts of thymidylate synthase-inhibited cells
E M Piall, N J Curtin, G W Aherne, et al.
British Journal of Cancer
|
November 21, 1998
Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064
K J Bowman, A White, B T Golding, et al.
British Journal of Cancer
|
July 2, 2009
Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines
T Zaremba, P Ketzer, M Cole, et al.
Journal of Hepatology
|
June 1, 1987
Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study
M F Bassendine, N J Curtin, H Loose, et al.
Seminars in Oncology
|
December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines
P G Smith, E Marshman, A H Calvert, et al.
Biochemical Pharmacology
|
February 28, 2001
Hypoxanthine transport in human tumour cell lines: relationship to the inhibition of hypoxanthine rescue by dipyridamole
E Marshman, G A Taylor, H D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Cellular ATP depletion by LY309887 as a predictor of growth inhibition in human tumor cell lines
X Lu, J Errington, V J Chen, et al.
British Journal of Cancer
|
September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue
N R Monks, D C Blakey, N J Curtin, et al.
British Journal of Cancer
|
July 20, 2000
Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
N R Monks, J A Calvete, N J Curtin, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Cancer Treatment Reviews
|
July 1, 2011
Defective homologous recombination in human cancers
A Cerbinskaite, A Mukhopadhyay, E R Plummer, et al.
Analytical Biochemistry
|
March 1, 1989
The quantitation by radioimmunoassay of 2'-deoxyuridine 5'-triphosphate in extracts of thymidylate synthase-inhibited cells
E M Piall, N J Curtin, G W Aherne, et al.
British Journal of Cancer
|
November 21, 1998
Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064
K J Bowman, A White, B T Golding, et al.
British Journal of Cancer
|
July 2, 2009
Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines
T Zaremba, P Ketzer, M Cole, et al.
Journal of Hepatology
|
June 1, 1987
Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study
M F Bassendine, N J Curtin, H Loose, et al.
Seminars in Oncology
|
December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines
P G Smith, E Marshman, A H Calvert, et al.
Biochemical Pharmacology
|
February 28, 2001
Hypoxanthine transport in human tumour cell lines: relationship to the inhibition of hypoxanthine rescue by dipyridamole
E Marshman, G A Taylor, H D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Cellular ATP depletion by LY309887 as a predictor of growth inhibition in human tumor cell lines
X Lu, J Errington, V J Chen, et al.
British Journal of Cancer
|
September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue
N R Monks, D C Blakey, N J Curtin, et al.
British Journal of Cancer
|
July 20, 2000
Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
N R Monks, J A Calvete, N J Curtin, et al.
Page
of 5